| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/15/2011 | US20110223608 Molecular detection and quantification of enterococci |
| 09/15/2011 | US20110223607 Circulating microrna as a marker for hepatocellular carcinoma |
| 09/15/2011 | US20110223606 Nucleic acid quantitation from tissue slides |
| 09/15/2011 | US20110223605 Multiple-sample microfluidic chip for DNA analysis |
| 09/15/2011 | US20110223604 Assay for the Measurement of IGF Type 1 Receptor and Insulin Receptor Expression |
| 09/15/2011 | US20110223603 Diagnosing and monitoring response to treatment of non-incontinent urological and related diseases |
| 09/15/2011 | US20110223602 Systems and Methods for Multiplex Analysis of PCR in Real Time |
| 09/15/2011 | US20110223601 Method for pairwise sequencing of target polynucleotides |
| 09/15/2011 | US20110223600 Method For Predicting Athletic Performance Potential |
| 09/15/2011 | US20110223599 Parasite detection via endosymbiont detection |
| 09/15/2011 | US20110223598 Method for real-time detection of salmonella in food using a cleavable chimeric probe |
| 09/15/2011 | US20110223597 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | US20110223596 Multiplex Detection Compositions, Methods, and Kits |
| 09/15/2011 | US20110223595 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia |
| 09/15/2011 | US20110223594 Methods, kits and compositions for determining severity and survival of heart failure in a subject |
| 09/15/2011 | US20110223593 Predicting a response to olanzapine |
| 09/15/2011 | US20110223592 Multiple fluorophore detector system |
| 09/15/2011 | US20110223591 Methods and device to constrain multicellular arrangements in stable, stationary and reproducible spatial configuration |
| 09/15/2011 | US20110223590 Single-molecule detection system and methods |
| 09/15/2011 | US20110223589 Solid Phase Nucleic Acid Extraction From Leukoreduced Blood |
| 09/15/2011 | US20110223588 Solid Phase Nucleic Acid Extraction From Small Sample Volumes, and Release of Controlled Quantities |
| 09/15/2011 | US20110223587 Optical particle characterization system |
| 09/15/2011 | US20110223586 Optical particle characterization system |
| 09/15/2011 | US20110223585 Assay for localized detection of analytes |
| 09/15/2011 | US20110223584 Oligonucleotides For Detecting Human Papilloma Virus In A Test Sample |
| 09/15/2011 | US20110223583 Devices and methods for providing concentrated biomolecule condensates to biosensing devices |
| 09/15/2011 | US20110223582 Cell culture device and method of culturing cells |
| 09/15/2011 | US20110223181 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 09/15/2011 | US20110223180 Methods and compositions related to a multi-methylation assay to predict patient outcome |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223172 Soluble Forms of Hendra and Nipah Virus F Glycoprotein and Uses Thereof |
| 09/15/2011 | US20110223157 Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 09/15/2011 | US20110223152 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers |
| 09/15/2011 | US20110223149 Peptidomimetic macrocycles |
| 09/15/2011 | US20110223140 Method for differentiation into retinal cells from stem cells |
| 09/15/2011 | US20110223110 Stable indium-containing semiconductor nanocrystals |
| 09/15/2011 | US20110223106 Granin proteins as markers of heart disease |
| 09/15/2011 | US20110223105 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 09/15/2011 | US20110223058 Structure, Synthesis, and Applications for Oligo Phenylene Ethynylenes |
| 09/15/2011 | US20110220570 Heavy metal remediation system |
| 09/15/2011 | DE112007001911B4 Gesteuerte Translokation eines Polymers in einem elektrolytischen Sensorsystem Controlled translocation of a polymer in an electrolytic sensor system |
| 09/15/2011 | DE102008058984B4 Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (SenRes-Test) Optimizing therapy for cancer patients by testing combinations of therapy by in vitro tests (SenRes test) |
| 09/15/2011 | DE102006037739B4 Vorrichtung zur Durchführung eines Analyseverfahrens, insbesondere zur Erkennung biochemischer Moleküle, und mit dieser Vorrichtung ausführbare Analyseverfahren Apparatus for carrying out an analytical procedure, particularly for the detection of biochemical molecules, and with this apparatus executable analysis method |
| 09/15/2011 | CA2792758A1 Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes |
| 09/15/2011 | CA2792469A1 Methods of testing for intracellular pathogens |
| 09/15/2011 | CA2792433A1 Full cold-pcr enrichment with reference blocking sequence |
| 09/15/2011 | CA2791724A1 Detection of methylated dna |
| 09/15/2011 | CA2791697A1 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2 |
| 09/15/2011 | CA2791247A1 Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy |
| 09/15/2011 | CA2791244A1 Androgen receptor isoforms and methods |
| 09/15/2011 | CA2696545A1 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization |
| 09/14/2011 | EP2365334A1 Peptide sequence that promotes tumor invasion |
| 09/14/2011 | EP2365331A2 Method to select a single antigen-specfic lymphocyte. |
| 09/14/2011 | EP2365329A1 Method of manufacturing planar bio-test strip and product thereof |
| 09/14/2011 | EP2365326A1 Biosensor for electrochemical measurement of 1,5-anhydroglucitol, and measuring method and measuring kit using the same |
| 09/14/2011 | EP2365325A1 Device for measuring extracellular potential and method of manufacturing the device |
| 09/14/2011 | EP2365324A2 Bridged element for detection of a target substance |
| 09/14/2011 | EP2365323A2 Bridged element for detection of a target substance |
| 09/14/2011 | EP2365098A2 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 09/14/2011 | EP2365097A1 Nucleic acid probe-based assays for prokaryotic and eukaryotic organisms |
| 09/14/2011 | EP2365096A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/14/2011 | EP2365095A1 Random array DNA analysis by hybridization |
| 09/14/2011 | EP2365093A2 Method for sequencing nucleic acid molecules |
| 09/14/2011 | EP2365092A1 Identification of tumors and tissues |
| 09/14/2011 | EP2365091A1 Method of screening for HtrA protease inhibitors useful for prophylaxis and therapy of a bacterial infection |
| 09/14/2011 | EP2365086A1 Novel omega-3 fatty acid desaturase family members and uses thereof |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365079A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2011 | EP2365078A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365074A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365073A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365062A1 Rapid production of monoclonal antibodies |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364989A1 Stable NAD/NADH-derivatives |
| 09/14/2011 | EP2364988A1 Stable NAD/NADH derivatives |
| 09/14/2011 | EP2364447A1 Methods for the isolation and identification of microorganisms |
| 09/14/2011 | EP2364446A1 Methods for separation and characterization of microorganisms using identifier agents |
| 09/14/2011 | EP2364372A1 Open and closed valve medication delivery system for high pressure injections |
| 09/14/2011 | EP2364371A1 Biomarkers for the detection of head and neck tumors |
| 09/14/2011 | EP2364370A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 09/14/2011 | EP2364369A1 Neuroblastoma prognostic multigene expression signature |
| 09/14/2011 | EP2364368A2 Methods of monitoring conditions by sequence analysis |
| 09/14/2011 | EP2364367A2 Methods, compositions, and devices utilizing microrna to determine physiological conditions |
| 09/14/2011 | EP2364356A1 Methods for detection, characterization and/or identification of microorganisms in a sealed container |
| 09/14/2011 | EP2364326A2 Methods for selecting protease resistant polypeptides |
| 09/14/2011 | EP2364325A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/14/2011 | EP2152910B1 Detecting triazole resistance in aspergillus |
| 09/14/2011 | EP2048246B1 Method for obtaining oligonucleotide |
| 09/14/2011 | EP2046986B1 Transcription infidelity, detection and uses thereof |
| 09/14/2011 | EP1963366B1 Methods for cyclic nucleotide determination |
| 09/14/2011 | EP1888788B1 Chemiluminescence proximity nucleic acid assay |
| 09/14/2011 | EP1877575B1 System for producing synthetic promoters |
| 09/14/2011 | EP1841885B1 Oligonucleotide probe pair for genotyping of kidd/jk erythrocyte system, methods and relative diagnostic kits |
| 09/14/2011 | EP1733234B1 Methods of determining allergen response using microarray immunoassay techinques |
| 09/14/2011 | EP1718661B1 A method for the simultaneous determination of blood group and platelet antigen genotypes |
| 09/14/2011 | EP1641937B1 Mutations in the slc40a1 gene associated to impaired iron homeostasis |
| 09/14/2011 | EP1573058B1 A method for improving protein production |
| 09/14/2011 | EP1563302B1 Methods for selecting treatment regimens and predicting outcomes in cancer patients |